Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Induction of Tumours with 1-(2-Tolylazo)-2-naphthol (Oil Orange TX)

Abstract

PEACOCK1 induced hepatomas in seven of seventeen mice surviving subcutaneous injection of oil orange E (1-benzeneazo-2-naphthol) for more than fourteen months. This substance was then in use as a food dye. Clayson2 has since suggested that it might be active by virtue of its in vivo reduction to 1-amino-2-naphthol. If this be so, it was thought that other compounds capable of being reduced to this amino-haphthol might be carcinogenic.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Peacock, P. R., Ann. Rep. Brit. Empire Cancer Campaign, 26, 198 (1948).

  2. Clayson, D. B., Brit. J. Cancer, 7, 460 (1953).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BONSER, G., CLAYSON, D. & JULL, J. Induction of Tumours with 1-(2-Tolylazo)-2-naphthol (Oil Orange TX). Nature 174, 879–880 (1954). https://doi.org/10.1038/174879b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/174879b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing